Istanbul - Delayed Quote TRY

Europower Enerji ve Otomasyon Teknolojileri Sanayi Ticaret Anonim Sirketi (EUPWR.IS)

26.26

-0.68

(-2.52%)

As of 5:04:43 PM GMT+3. Market Open.

Gap tariff hit, Ulta forecast, Dell outlook: Trending Tickers

Gap (GAP) stock plummets as the projected cost of tariffs weighs on the retailer's outlook. Ulta (ULTA) lifts its annual profit outlook, highlighting resilient beauty demand. Dell Technologies (DELL) raises its full-year outlook, citing artificial intelligence (AI)–driven demand. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here.

Yahoo Finance Video 33 minutes ago

ULTA

GAP

DELL
Should crypto be part of your retirement? Here's what to know.

The US Labor Department removed guidance discouraging employer-sponsored retirement plans from holding crypto. 401 Financial principal and founder, Tyrone Ross, sits down with Brad Smith to discuss what the change signals about the asset class and outlines what you need to know about investing in crypto for retirement. To watch more expert insights and analysis on the latest market action, check out more Wealth here.

Yahoo Finance Video 3 hours ago

BTC-USD
Gap's Q1 earnings beat overshadowed by up to $300M tariff hit

Gap (GAP) stock is plunging in after-hours trading as investors focus on the retailer's expected tariff hit rather than its first quarter earnings beat. The company's revenue was $3.46 billion, compared to the $3.42 billion expected, while earnings per share (EPS) came in at $0.51, better than the $0.45 analysts estimated. The retailer said it expects the tariff impact to cost up to $150 million in its 2025 operating income and $250–300 million in its gross estimated incremental cost. Gap maintained its full-year outlook but noted that this guidance doesn't reflect potential tariff impacts. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime here.

Yahoo Finance Video 17 hours ago

GAP
Uber, Tesla robotaxis, Synopsys guidance: Trending Tickers

Uber (UBER) shares slide into negative territory on Thursday amid speculation around Tesla's (TSLA) rollout of robotaxis in Austin, Texas, on June 12. Catch Tesla investor Ross Gerber share his thoughts on Waymo's robotaxi model as compared to Tesla's plans. Synopsys (SNPS) suspends its guidance for its current fiscal third quarter and full-year 2025 as it digests new export controls on shipments to China. To watch more expert insights and analysis on the latest market action, check out more Market Domination here.

Yahoo Finance Video 18 hours ago

TSLA

SNPS

UBER
Ulta Stock Jumps as Beauty Product Spending Continues

Ulta Beauty exceeded profit and sales estimates as consumers look to beauty products as a "comfort and escape."

Investopedia 18 minutes ago

ULTA
Airbnb shares dip as Truist cuts stock to Sell on weak summer trends, valuation

Investing.com -- Shares in Airbnb Inc (NASDAQ:ABNB) fell roughly 2% at market open Friday after Truist Securities downgraded the stock to Sell from Hold due to soft summer leisure trends and concerns over valuation.

Investing.com 20 minutes ago

ABNB

TFC

PK
UiPath Stock Rises After Earnings, Guidance Hike. Why Wall Street Is More Cautious.

The automation-software company pushed back on fears that cuts in U.S. federal spending may hurt its financial results.

Barrons.com 21 minutes ago

PATH
Zscaler Stock Jumps. Why It’s Defying the Cybersecurity Earnings Slump.

The cybersecurity stock rose early Friday, making it an outlier in what's been a tough earnings season for the sector.

Barrons.com 25 minutes ago

ZS
Costco Defies Tariff Shifts With Higher Profit, Lower Prices

(Bloomberg) -- Costco Wholesale Corp. posted better-than-expected earnings in the third quarter, a sign that the nation’s largest club chain is flexing its scale and devoted following to navigate tariffs and economic turbulence. Most Read from BloombergNYC Congestion Toll Brings In $216 Million in First Four MonthsNow With Colorful Blocks, Tirana’s Pyramid Represents a Changing AlbaniaThe Economic Benefits of Paying Workers to MoveNY Wins Order Against US Funding Freeze in Congestion FightWhy Ar

Bloomberg 37 minutes ago

TGT

WMT

PG
Airbnb, Zscaler downgraded: Wall Street's top analyst calls

Airbnb, Zscaler downgraded: Wall Street's top analyst calls

The Fly 39 minutes ago

ABNB

ZS

PVH
Summit Therapeutics Study Is a Win for China Biopharma Deals. Why the Stock Is Down.

The trial was meant to answer the biggest question in biotech: What happens when U.S. companies test promising new Chinese cancer immunotherapies in western countries?

Barrons.com 52 minutes ago

SMMT
Summit Therapeutics, A Top 1% Biotech, Plummets On A High-Profile Failure

Summit Therapeutics stock plunged Friday after its highly watched cancer drug failed to significantly improve overall survival.

Investor's Business Daily 57 minutes ago

SMMT

MRK
Zscaler Had 'Breakout' Third Quarter Amid Strong Demand for AI Security Solutions, Wedbush Says

Zscaler's (ZS) fiscal third-quarter results marked another "breakout" moment for the company as it c

PREMIUM
MT Newswires 1 hour ago

ZS
Crypto Stock Bolts 1078%, Pharma Bro Martin Shkreli Places A Bet

Former "Pharma bro" Martin Shkreli has bought into SharpLink Gaming. SBET is turning into a crypto stock as it builds ETH treasury.

Investor's Business Daily 1 hour ago

RSI

SRAD

SBET
Regeneron Pharmaceuticals Crashes 12% On A Surprise Sanofi-Tied Failure

Regeneron stock crashed Friday after the company's Sanofi-partnered COPD treatment unexpectedly failed in a Phase 3 study.

Investor's Business Daily 1 hour ago

REGN

SNY

SNYNF
Dell Shares Climb After Raising Profit Outlook on AI Boom

Dell's AI Push Ignites 2% Pre-Market Stock Jump--Backlog Tops $14B

GuruFocus.com 1 hour ago

DELL
Costco's $1.50 hot dog is still a winner

The $1.50 Costco hot dog — a still point in a turning world, immune to tariffs, inflation, or even Jay Powell — remains the most reliable deal in America. In a time of relentless volatility, the Costco hot dog stands firm.

Quartz 1 hour ago

COST
Regeneron Stock Plunges. Why a Drug Trial Missed the Mark.

Regeneron declined 10% to $544 in early trading. U.S.-listed shares of Sanofi were down 4.8%. The partners had touted their drug candidate itepekimab as a possible treatment for chronic obstructive pulmonary disease, or COPD, a condition caused by damage to the lungs that makes breathing difficult.

Barrons.com 1 hour ago

REGN

SNY
Regeneron, Sanofi Stock Falls After Uneven Smoker's Lung Drug Data

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) and Sanofi SA (NASDAQ:SNY) on Friday announced results from two Phase 3 trials of itepekimab in chronic obstructive pulmonary disease (COPD) patients. Phase 3 AERIFY-1 trial evaluating itepekimab in adults who were former smokers with inadequately controlled COPD met the primary endpoint of significantly reducing moderate or severe acute exacerbations by 27% compared to placebo at week 52, a clinically meaningful benefit. A second Phase 3 trial, AERI

Benzinga 1 hour ago

REGN

SNY
Is IonQ Stock a Buy Now?

IonQ's share price is flying high, but quantum computing is an unproven market. IonQ stock is expensive, and the company still has a lot to prove. Aside from artificial intelligence, quantum computing may be one of the hottest tech trends investors are following right now.

Motley Fool 1 hour ago

IONQ-WS

Performance Overview

Return	EUPWR.IS	BIST 100 (XU100.IS)
YTD	-20.86%	-8.37%
1-Year	-32.32%	-14.06%
3-Year	+76.40%	+256.42%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Europower Enerji ve Otomasyon Teknolojileri Sanayi Ticaret Anonim Sirketi (EUPWR.IS)

Related News

Gap tariff hit, Ulta forecast, Dell outlook: Trending Tickers

Should crypto be part of your retirement? Here's what to know.

Gap's Q1 earnings beat overshadowed by up to $300M tariff hit

Uber, Tesla robotaxis, Synopsys guidance: Trending Tickers

Ulta Stock Jumps as Beauty Product Spending Continues

Airbnb shares dip as Truist cuts stock to Sell on weak summer trends, valuation

UiPath Stock Rises After Earnings, Guidance Hike. Why Wall Street Is More Cautious.

Zscaler Stock Jumps. Why It’s Defying the Cybersecurity Earnings Slump.

Costco Defies Tariff Shifts With Higher Profit, Lower Prices

Airbnb, Zscaler downgraded: Wall Street's top analyst calls

Summit Therapeutics Study Is a Win for China Biopharma Deals. Why the Stock Is Down.

Summit Therapeutics, A Top 1% Biotech, Plummets On A High-Profile Failure

Zscaler Had 'Breakout' Third Quarter Amid Strong Demand for AI Security Solutions, Wedbush Says

Crypto Stock Bolts 1078%, Pharma Bro Martin Shkreli Places A Bet

Regeneron Pharmaceuticals Crashes 12% On A Surprise Sanofi-Tied Failure

Dell Shares Climb After Raising Profit Outlook on AI Boom

Costco's $1.50 hot dog is still a winner

Regeneron Stock Plunges. Why a Drug Trial Missed the Mark.

Regeneron, Sanofi Stock Falls After Uneven Smoker's Lung Drug Data

Is IonQ Stock a Buy Now?

Performance Overview